Manzi Lina, Sperandeo Luca, Forzano Imma, Castiello Domenico Simone, Florimonte Domenico, Paolillo Roberta, Santoro Ciro, Mancusi Costantino, Di Serafino Luigi, Esposito Giovanni, Gargiulo Giuseppe
Department of Advanced Biomedical Sciences, Federico II University of Naples, 80131 Naples, Italy.
Diagnostics (Basel). 2024 Jan 7;14(2):136. doi: 10.3390/diagnostics14020136.
Heart failure (HF) has a global prevalence of 1-2%, and the incidence around the world is growing. The prevalence increases with age, from around 1% for those aged <55 years to >10% for those aged 70 years or over. Based on studies in hospitalized patients, about 50% of patients have heart failure with reduced ejection fraction (HFrEF), and 50% have heart failure with preserved ejection fraction (HFpEF). HF is associated with high morbidity and mortality, and HF-related hospitalizations are common, costly, and impact both quality of life and prognosis. More than 5-10% of patients deteriorate into advanced HF (AdHF) with worse outcomes, up to cardiogenic shock (CS) condition. Right heart catheterization (RHC) is essential to assess hemodynamics in the diagnosis and care of patients with HF. The aim of this article is to review the evidence on RHC in various clinical scenarios of patients with HF.
心力衰竭（HF）在全球的患病率为1%-2%，且全球发病率呈上升趋势。患病率随年龄增长而增加，55岁以下人群约为1%，70岁及以上人群则超过10%。基于对住院患者的研究，约50%的患者为射血分数降低的心力衰竭（HFrEF），50%为射血分数保留的心力衰竭（HFpEF）。HF与高发病率和死亡率相关，与HF相关的住院很常见，费用高昂，且会影响生活质量和预后。超过5%-10%的患者会恶化为预后更差的晚期HF（AdHF），直至心源性休克（CS）状态。右心导管检查（RHC）对于评估HF患者诊断和治疗中的血流动力学至关重要。本文旨在综述HF患者各种临床情况下RHC的相关证据。
